Skip to main content

Advertisement

ADVERTISEMENT

Volume 24 - Issue 3 - March 2012

Feature

Original Contribution
02/29/2012

Partha Sardar, MD1, Saurav Chatterjee, MD2, Debabrata Mukherjee, MD, MS3, Kirk N. Garratt, MD1

1Lenox Hill Cardiovascular Institute, New York, New York
2Department of Internal Medicine, Maimonides Medical Center, Brooklyn, New York

3the Department of Internal Medicine, Texas Tech Health Sciences Center, El Paso, Texas

Partha Sardar, MD1, Saurav Chatterjee...
Stent restenosis remains a common complication of bare-metal stent (BMS) implantation. Even in the drug-eluting stent (DES) era, there remains a significant proportion of patients who may not be eligible for DES due to inability to comply...
Stent restenosis remains a common complication of bare-metal stent (BMS) implantation. Even in the drug-eluting stent (DES) era, there remains a significant proportion of patients who may not be eligible for DES due to inability to comply...
Stent restenosis remains a...
02/29/2012
Journal of Invasive Cardiology
Original Contribution
02/29/2012

Alessandro Lupi, MD1, Andrea Rognoni, MD1, Gioel Gabrio Secco, MD2, Maurizio Lazzero, MD1,
Laura Plebani, MD1, Giuseppe Cossa, MD3, Danilo Reale, MD3, Federico Nardi, MD4, Mara Sansa, MD1, Angelo S. Bongo, MD1

Alessandro Lupi, MD1, Andrea Rognoni,...
Abstract: Background. Reported complication rates after vascular closure device deployment or femoral manual compression (MC) are similar. However, the features and severity of such complications have never been thoroughly evaluated. Methods...
Abstract: Background. Reported complication rates after vascular closure device deployment or femoral manual compression (MC) are similar. However, the features and severity of such complications have never been thoroughly evaluated. Methods...
Abstract: Background. Reported...
02/29/2012
Journal of Invasive Cardiology
Original Contribution
02/29/2012

Renicus S. Hermanides, MD1, Jan Paul Ottervanger, MD, PhD1, Jurrien M. ten Berg, MD, PhD2
A.T. Marcel Gosselink, MD, PhD1, Gert van Houwelingen, MD3, Jan-Henk E. Dambrink, MD, PhD1,
Pieter R. Stella, MD, PhD4, Christian Hamm, MD, PhD5, Arnoud W.J. van ’t Hof, MD, PhD1, on behalf of the On-TIME 2 Trial Investigators

Renicus S. Hermanides, MD1, Jan Paul ...
Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...
Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...
Abstract: Aims. The aim of this...
02/29/2012
Journal of Invasive Cardiology

Insights

Commentary
02/29/2012

Michael P. Thomas, MD and Hitinder S. Gurm, MD

Michael P. Thomas, MD and Hitinder S....
Vascular access complications from diagnostic coronary angiography and percutaneous intervention are a major cause of morbidity and mortality. The use of vascular closure devices is common practice and their use to decrease complications is...
Vascular access complications from diagnostic coronary angiography and percutaneous intervention are a major cause of morbidity and mortality. The use of vascular closure devices is common practice and their use to decrease complications is...
Vascular access complications...
02/29/2012
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement